Getting Production Down PAT

By Siemens Industry, Inc.

Sipat helps Wyeth become one of the first companies to align with the Process Analytical Technology (PAT) guidelines issued by the US Food and Drug Administration (FDA).

The 10th-largest pharmaceutical company in the world, Wyeth Pharmaceuticals, features strongly in the development of innovative products in the pharmaceutical sector and biotechnology. The company supplies trendsetting products in the fields of women’s health, the neurosciences, musculoskeletal abnormalities, cardiovascular therapy, hemophilia, immunology, oncology, vaccines, and infectious diseases.

Built in 1992, Wyeth’s Newbridge manufacturing facility in Ireland is one of the largest solid-dosage pharmaceutical plants in Europe. It is there that Wyeth recently established the first of a number of Pharmaceutical Development Centers (PDCs). The multifunctional center supports process development for products in the development phase and for products already available in the market.